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1682-606X/Copyright ª 2015, TaiwanSummary Pseudothrombocytopenia (PTCP) is an in vitro phenomenon of a spuriously re-
ported low platelet count, typically caused by EDTA-dependent platelet aggregation. PTCP
has no clinical significance, but misdiagnosis may lead to unnecessary diagnostic tests and
treatment. In this study, two cases of EDTA-dependent PTCP are discussed to emphasize the
importance of differentiating PTCP from true thrombocytopenia. The first case is of a 77-
year-old woman with a femoral neck fracture, and the second case is of a 66-year-old woman
with a frozen shoulder. Both cases showed low platelet counts in their routine blood tests and
were ultimately proven to have PTCP. When identifying a patient with a low platelet count
without any hematology disease, family history, and bleeding tendency manifestation, PTCP
should also be considered. Re-examining blood samples with tubes containing other anticoag-
ulants and a peripheral blood smear examination can help identify PTCP.
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Pseudothrombocytopenia (PTCP) is an in vitro phenomenon
of platelet aggregation that results in spurious reporting of
a low platelet count by automatic cell counters, which are
typically EDTA dependent.1 In general, EDTA, a calcium
chelator, is considered a safe and reliable anticoagulant for
a complete blood count test because of its stability in blood
cell counting and sizing. However, platelet clumping occurs
occasionally. People with malignancy, chronic liver disease,
infection, pregnancy, autoimmune diseases, andElsevier Taiwan LLC. All rights reserved.
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dependent PTCP. It has also been observed in disease-free
patients.2,3 Platelet clumping in the presence of EDTA is
caused by an autoantibody against glycoprotein IIb/IIIa
located on the cell membrane of platelets.4,5 Although
other anticoagulants such as heparin and sodium citrate
rarely induce such a phenomena, it is possible.5,6 Misdiag-
nosis of PTCP leads to unnecessary diagnostic tests and
treatments, such as bone marrow biopsy, holding surgery,
splenectomy, steroid therapy, and platelet transfusion.7
Therefore, when a low platelet count is noted, PTCP must
also be considered. In this study, we report two cases of
EDTA-dependent PTCP.
2. Case reports
2.1. Case 1
A 77-year-old female patient with no personal or family
history of bleeding was admitted with a left femoral neck
fracture. A preoperative evaluation of complete blood
count revealed thrombocytopenia (5700 platelets/mL).
Other blood parameters were normal. The patient denied
melena, hematuria, or easy bruising, and had no history of
drug use or recent infection. On physical examination, no
petechia, purpura, or lymphadenopathy was noted.0
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Figure 1 Platelet count of the blood sample collected with
EDTA decreased over time.
Figure 2 (A) A peripheral blood smear examined immediately af
count was 511,000/mL; (B) 5 minutes later, the platelets had clu
automatic cell counter was 458,000/mL.Because of the low platelet count, she received a blood
transfusion with platelets (24 units). The platelet count was
elevated to 126,000/mL. The surgery for dynamic hip screw
went smoothly without any bleeding complications. Two
months later, she was admitted again for a total hip
replacement because of an implant failure. The platelet
count varied during hospitalization as follows: 26,100/mL,
44,600/mL, 14,600/mL, 305,000/mL, and 69,100/mL. Pres-
ence of autoantibodies C3 and C4 were negative. Autoim-
mune diseases were excluded. No splenomegaly on
abdominal sonography was noted. The dramatic change in
the platelet count prompted suspicion of PTCP caused by
EDTA or an error in the autoanalyzer. Two blood samples
were collected again with two different anticoagulants,
EDTA and heparin, respectively, for further study. The
platelet count of the blood sample collected with EDTA
decreased over time (Fig. 1). A peripheral blood smear
examined immediately after blood collection showed no
platelet clumping (Fig. 2A), while the platelet clumped 5
minutes after withdrawal (Fig. 2B). The platelet count of
the blood sample collected with heparin was still within the
normal range 120 minutes after blood collection. Based on
these results, a final diagnosis of EDTA-dependent PTCP was
made. The total hip replacement was completed with no
bleeding complications.2.2. Case 2
A 66-year-old female patient with a frozen shoulder was
admitted to hospital for a manipulation. Her platelet count
was 49,500/mL and her prothrombin time, activated partial
thromboplastin time, and bleeding time were all within
normal ranges. She had no hematologic personal or family
history. A physical examination revealed no signs of
bleeding tendency. According to her medical record, a
complete blood count test taken 3 months previously did
not show thrombocytopenia. Based on prior experience of
such a case, EDTA-dependent PTCP was considered, and
was confirmed when a peripheral blood smear examination
showed platelet clumping. Hence, an unnecessary blood
transfusion was avoided in this case.ter blood collection showed no platelet clumping. The platelet
mped together (arrows). The platelet count reported by the
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Figure 3 The algorithm for identifying
pseudothrombocytopenia.
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Thrombocytopenia is caused by increased destruction of
platelets (hemolytic uremic syndrome, immune thrombo-
cytopenia, and disseminated intravascular coagulation),
decreased production of platelets (leukemia, sepsis, human
immunodeficiency virus, and decreased production of
thrombopoietin), hemodilution, or the use of certain drugs
(valproic acid, methotrexate, pantoprazole, and heparin).8
PTCP caused by platelet aggregation in blood containing
EDTA should also be considered when a low platelet count is
noted. Since 1973, EDTA-dependent PTCP has been widely
reported.1 The prevalence rate of EDTA-dependent PTCP is
approximately 0.1e2% in hospitalized patients.2,8 The
mechanism involves the binding of an antiplatelet autoan-
tibody to the glycoprotein located on the cell membrane of
platelets. A combined action of the chelating effect of
EDTA on calcium ions and low temperature affects the
platelet membrane glycoprotein complex IIb/IIIa and re-
veals the epitope of glycoprotein IIb, which normally re-
mains hidden in the glycoprotein complex IIb/IIIa.4 When
the autoantibody binds to the epitope of glycoprotein IIb,
platelet aggregation occurs.4,5 The primary antibodiesinvolved in this mechanism are immunoglobulin (Ig)G, IgM,
and IgA, and combinations of IgG and IgM, or IgA and IgG are
also observed.7 Most of the agglutinins react strongly at
room temperature or low temperatures, but some aggluti-
nins are temperature-independent or react most strongly at
37C.5
Methods employed for distinguishing true thrombocyto-
penia from PTCP include using other anticoagulants (sodium
citrate, oxalate, and heparin), elevating the temperature
of a blood sample to 37C, examining a blood sample con-
taining EDTA as soon as possible, examining a blood smear
under a microscope, and adding kanamycin or amikacin to a
blood sample collected with EDTA.6 Automated platelet
clump count is also available for screening EDTA-dependent
PTCP.9 Misclassification of PTCP leads to unnecessary
diagnostic tests and treatment. In Case 1, we conducted an
unnecessary platelet transfusion and delayed surgery on
the patient, which could have led to complications after
the transfusion, making the patient anxious. Additional
aggressive treatments, such as splenectomy, steroid ther-
apy, and bone marrow biopsy have also been reported.7
When a patient with a low platelet count but without any
hematology disease, family history, and bleeding tendency
manifestation is identified, PTCP should also be considered.
When EDTA-dependent PTCP is suspected, a blood sample of
the patient with tubes containing other anticoagulants can
be re-evaluated. Later on, the simple, inexpensive, and
diagnostic method of peripheral blood smear examination
can be employed to confirm platelet clumping (Fig. 3).References
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